Yang et al. reported that a combination of isoniazid (INH), MAO-A inhibitor and tumor-targeting hepatomethine cyanine dyes proved to be a highly promising treatment tool for advanced PCa [127]. Here, MAOA is linked to posterior cortical atrophy.